UNIVERSAL BIOLOGY NORWAY AS

5147 FYLLINGSDALEN

Finances

Share Ownership

Return on Equity

131,79 %

Current Ratio

1,41

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	3 531 000	2 819 000	3 644 000	3 994 000
Net Income	771 000	35 000	9 000	−125 000
Total Assets	1 765 000	747 000	1 121 000	2 272 000
Total Equity	585 000	−186 000	−221 000	−231 000

Income (NOK)	2022	2021	2020	2019
Revenue	3 531 000	2 819 000	3 644 000	3 994 000
Expenditure	2 737 000	2 757 000	3 567 000	4 045 000
Operating Profit	794 000	62 000	78 000	−51 000
Financial Income	20 000	25 000	3 000	0
Financial Costs	43 000	52 000	72 000	74 000
Financial Balance	−23 000	−27 000	−69 000	−74 000
Earnings Before Tax	771 000	35 000	9 000	−125 000
Tax	0	0	0	0
Net Income	771 000	35 000	9 000	−125 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	96 000	0	478 000	553 000
Total Current Assets	1 669 000	747 000	643 000	1 719 000
Total Assets	1 765 000	747 000	1 121 000	2 272 000
Total Retained Equity	435 000	−336 000	−371 000	−381 000
Total Equity	585 000	−186 000	−221 000	−231 000
Total Long-Term Debt	0	0	394 000	461 000
Total Current Debt	1 180 000	934 000	948 000	2 042 000
Total Equity and Debt	1 765 000	747 000	1 121 000	2 272 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	3 531 000	2 819 000	3 644 000	3 994 000
Other Income	0	0	0	0
Revenue	3 531 000	2 819 000	3 644 000	3 994 000
Cost of Goods Sold	1 581 000	1 573 000	2 958 000	1 892 000
Salary Costs	407 000	372 000	407 000	934 000
Depreciation	0	0	75 000	75 000
Impairment	0	0	0	0
Expenditure	2 737 000	2 757 000	3 567 000	4 045 000
Operating Profit	794 000	62 000	78 000	−51 000
Financial Income	20 000	25 000	3 000	0
Financial Costs	43 000	52 000	72 000	74 000
Financial Balance	−23 000	−27 000	−69 000	−74 000
Dividends	0	0	0	0
Net Income	771 000	35 000	9 000	−125 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	96 000	0	478 000	553 000
Total Tangible Assets	96 000	0	478 000	553 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	96 000	0	478 000	553 000
Stock	1 483 000	545 000	599 000	1 513 000
Total Investments	0	0	0	0
Cash, Bank	12 000	−9 000	−11 000	10 000
Total Current Assets	1 669 000	747 000	643 000	1 719 000
Total Assets	1 765 000	747 000	1 121 000	2 272 000
Total Equity	585 000	−186 000	−221 000	−231 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	394 000	461 000
Creditors	417 000	561 000	385 000	423 000
Unpaid Taxes	123 000	52 000	65 000	100 000
Dividends	0	0	0	0
Other Current Debt	447 000	29 000	213 000	847 000
Total Current Debt	1 180 000	934 000	948 000	2 042 000
Total Equity and Debt	1 765 000	747 000	1 121 000	2 272 000

Financial indicators	2022	2021	2020	2019
Return on Equity	131,79 %	−18,82 %	−4,07 %	54,11 %
Debt-to-Equity Ratio	0	−0	−1,78	−2
Operating Profit Margin	22,49 %	2,2 %	2,14 %	−1,28 %
Current Ratio	1,41	0,8	0,68	0,84
Quick Ratio	−5,51	1,92	1,84	3,25
Equity Ratio	0,33	−0,25	−0,2	−0,1
Gross Profit Margin	55,23 %	44,2 %	18,83 %	52,63 %